ActBlue Co., Ltd.
SZSE:300816.SZ
25.51 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 946.541 | 1,046.542 | 816.392 | 866.146 | 677.109 | 565.979 | 445.249 | 372.94 | 152.526 | 157.931 |
| Cost of Revenue
| 733.404 | 866.481 | 676.651 | 665.831 | 434.007 | 361.961 | 282.18 | 243.027 | 89.336 | 86.094 |
| Gross Profit
| 213.137 | 180.061 | 139.74 | 200.315 | 243.102 | 204.018 | 163.069 | 129.914 | 63.19 | 71.837 |
| Gross Profit Ratio
| 0.225 | 0.172 | 0.171 | 0.231 | 0.359 | 0.36 | 0.366 | 0.348 | 0.414 | 0.455 |
| Reseach & Development Expenses
| 52.258 | 62.528 | 75.629 | 47.696 | 35.445 | 31.794 | 22.459 | 23.691 | 14.793 | 10.808 |
| General & Administrative Expenses
| 19.862 | 20.052 | 22.052 | 22.336 | 8.837 | 5.861 | 6.393 | 7.035 | 8.365 | 37.882 |
| Selling & Marketing Expenses
| 10.896 | 42.798 | 48.288 | 47.449 | 51.543 | 38.586 | 30.747 | 32.988 | 12.888 | 9.476 |
| SG&A
| 30.758 | 54.56 | 70.341 | 69.785 | 60.38 | 44.446 | 37.14 | 40.023 | 21.253 | 47.358 |
| Other Expenses
| 63.258 | 50.915 | 0.617 | 0.586 | 3.904 | 3.782 | 7.395 | -0.119 | 3.494 | 4.827 |
| Operating Expenses
| 146.274 | 168.003 | 145.868 | 114.815 | 89.451 | 78.751 | 67.279 | 68.428 | 41.668 | 59.242 |
| Operating Income
| 66.863 | 12.058 | -22.576 | 73.046 | 140.604 | 113.985 | 87.662 | 51.325 | 16.961 | 10.458 |
| Operating Income Ratio
| 0.071 | 0.012 | -0.028 | 0.084 | 0.208 | 0.201 | 0.197 | 0.138 | 0.111 | 0.066 |
| Total Other Income Expenses Net
| -1.347 | -0.258 | 0.617 | 0.586 | 3.904 | 3.782 | 7.395 | -0.119 | 3.494 | 4.827 |
| Income Before Tax
| 65.516 | 11.8 | -21.959 | 73.632 | 144.509 | 117.767 | 95.058 | 51.206 | 20.455 | 15.285 |
| Income Before Tax Ratio
| 0.069 | 0.011 | -0.027 | 0.085 | 0.213 | 0.208 | 0.213 | 0.137 | 0.134 | 0.097 |
| Income Tax Expense
| 8.231 | -2.23 | -10.075 | 7.15 | 18.97 | 15.329 | 12.395 | 6.882 | 3.381 | 6.086 |
| Net Income
| 49.878 | 10.689 | -10.544 | 69.672 | 125.394 | 103.378 | 82.89 | 44.319 | 17.075 | 9.198 |
| Net Income Ratio
| 0.053 | 0.01 | -0.013 | 0.08 | 0.185 | 0.183 | 0.186 | 0.119 | 0.112 | 0.058 |
| EPS
| 0.62 | 0.13 | -0.13 | 0.87 | 1.57 | 1.29 | 1.38 | 0.74 | 0.28 | 0.41 |
| EPS Diluted
| 0.62 | 0.13 | -0.13 | 0.87 | 1.57 | 1.29 | 1.38 | 0.74 | 0.28 | 0.41 |
| EBITDA
| 125.999 | 70.895 | 35.264 | 102.69 | 139.899 | 129.159 | 104.787 | 58.454 | 24.359 | 15.006 |
| EBITDA Ratio
| 0.133 | 0.068 | 0.043 | 0.119 | 0.207 | 0.228 | 0.235 | 0.157 | 0.16 | 0.095 |